TotalMarketCap

Palatin Technologies

PTNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$10.508 M

$5.90 -1.99%

Close of 6 Nov 2026

As of 6 Nov 2026, Palatin Technologies (PTN) has a market capitalization of $10.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$17.3M

Loss-making

Shares outstanding

1,780,939

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #409Cellectar BiosciencesCLRB$11.0M
  2. #410Lisata TherapeuticsLSTA$10.8M
  3. #411Palatin TechnologiesPTN$10.5M
  4. #412BiovieBIVI$10.5M
  5. #413CytoMed TherapeuticsGDTC$10.4M

What if Palatin Technologies were worth as much as…

Open the what-if tool →

Gold $28.2T

$15,855,048

Per share 2,687,296× higher

Bitcoin $1.53T

$857,889.06

Per share 145,405× higher

Apple $5.02T

$2,816,370

Per share 477,351× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Palatin Technologies are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.